Cargando…

Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma

BACKGROUND: Nasopharyngeal carcinoma (NPC) is a malignant disease with an enigmatic etiology. NPC associates with Epstein-Barr virus (EBV) and human papillomaviruses (HPVs), while immunological factors also play a role in carcinogenesis. Toll-like receptors (TLRs) are pattern recognition receptors t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruuskanen, Miia, Leivo, Ilmo, Minn, Heikki, Vahlberg, Tero, Haglund, Caj, Hagström, Jaana, Irjala, Heikki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593602/
https://www.ncbi.nlm.nih.gov/pubmed/31238894
http://dx.doi.org/10.1186/s12885-019-5816-9
_version_ 1783430084656365568
author Ruuskanen, Miia
Leivo, Ilmo
Minn, Heikki
Vahlberg, Tero
Haglund, Caj
Hagström, Jaana
Irjala, Heikki
author_facet Ruuskanen, Miia
Leivo, Ilmo
Minn, Heikki
Vahlberg, Tero
Haglund, Caj
Hagström, Jaana
Irjala, Heikki
author_sort Ruuskanen, Miia
collection PubMed
description BACKGROUND: Nasopharyngeal carcinoma (NPC) is a malignant disease with an enigmatic etiology. NPC associates with Epstein-Barr virus (EBV) and human papillomaviruses (HPVs), while immunological factors also play a role in carcinogenesis. Toll-like receptors (TLRs) are pattern recognition receptors that participate in the immunological defence against pathogens, but their functions are also linked to cancer. METHODS: In our whole population-based study, we retrieved 150 Finnish NPC cases and studied their tumour samples for TLR1, TLR2, TLR4, TLR5, TLR7, and TLR9 expressions by immunohistochemistry, and for the presence of EBV and high-risk HPVs with EBV RNA and HPV E6/E7 mRNA in situ hybridizations. In addition, we analyzed the TLR expression patterns according to age, tumour histology, EBV/HPV status, and outcome. RESULTS: We found that all TLRs studied were highly expressed in NPC. Viral status of the tumours varied, and 62% of them were EBV-positive, 14% HPV-positive, and 24% virus-negative. The tumours with strong TLR2(nucl) or TLR5 expression were mostly virus-negative or HPV-positive keratinizing squamous cell carcinomas, and the patients with these tumours were significantly older than those with mild or negative TLR2(nucl)/TLR5 expression. In Kaplan-Meier analysis, the patients with strong TLR5 expression had worse survival compared to the patients with negative or mild TLR5 expression, but the results were linked to other patient and tumour characteristics. In multivariable-adjusted Cox regression analysis, the patients with positive TLR7 tumour expression had better overall survival than those with no TLR7 expression. The 5-year overall survival rates according to TLR7 expression were 66% (mild), 52% (moderate or strong), and 22% (negative). CONCLUSIONS: TLRs are highly expressed in non-endemic NPC. Intensity of TLR2 and TLR5 expressions correlate with viral status, and TLR7 seems to be an independent prognostic factor of non-endemic NPC.
format Online
Article
Text
id pubmed-6593602
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65936022019-07-09 Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma Ruuskanen, Miia Leivo, Ilmo Minn, Heikki Vahlberg, Tero Haglund, Caj Hagström, Jaana Irjala, Heikki BMC Cancer Research Article BACKGROUND: Nasopharyngeal carcinoma (NPC) is a malignant disease with an enigmatic etiology. NPC associates with Epstein-Barr virus (EBV) and human papillomaviruses (HPVs), while immunological factors also play a role in carcinogenesis. Toll-like receptors (TLRs) are pattern recognition receptors that participate in the immunological defence against pathogens, but their functions are also linked to cancer. METHODS: In our whole population-based study, we retrieved 150 Finnish NPC cases and studied their tumour samples for TLR1, TLR2, TLR4, TLR5, TLR7, and TLR9 expressions by immunohistochemistry, and for the presence of EBV and high-risk HPVs with EBV RNA and HPV E6/E7 mRNA in situ hybridizations. In addition, we analyzed the TLR expression patterns according to age, tumour histology, EBV/HPV status, and outcome. RESULTS: We found that all TLRs studied were highly expressed in NPC. Viral status of the tumours varied, and 62% of them were EBV-positive, 14% HPV-positive, and 24% virus-negative. The tumours with strong TLR2(nucl) or TLR5 expression were mostly virus-negative or HPV-positive keratinizing squamous cell carcinomas, and the patients with these tumours were significantly older than those with mild or negative TLR2(nucl)/TLR5 expression. In Kaplan-Meier analysis, the patients with strong TLR5 expression had worse survival compared to the patients with negative or mild TLR5 expression, but the results were linked to other patient and tumour characteristics. In multivariable-adjusted Cox regression analysis, the patients with positive TLR7 tumour expression had better overall survival than those with no TLR7 expression. The 5-year overall survival rates according to TLR7 expression were 66% (mild), 52% (moderate or strong), and 22% (negative). CONCLUSIONS: TLRs are highly expressed in non-endemic NPC. Intensity of TLR2 and TLR5 expressions correlate with viral status, and TLR7 seems to be an independent prognostic factor of non-endemic NPC. BioMed Central 2019-06-25 /pmc/articles/PMC6593602/ /pubmed/31238894 http://dx.doi.org/10.1186/s12885-019-5816-9 Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Ruuskanen, Miia
Leivo, Ilmo
Minn, Heikki
Vahlberg, Tero
Haglund, Caj
Hagström, Jaana
Irjala, Heikki
Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma
title Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma
title_full Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma
title_fullStr Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma
title_full_unstemmed Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma
title_short Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma
title_sort expression of toll-like receptors in non-endemic nasopharyngeal carcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593602/
https://www.ncbi.nlm.nih.gov/pubmed/31238894
http://dx.doi.org/10.1186/s12885-019-5816-9
work_keys_str_mv AT ruuskanenmiia expressionoftolllikereceptorsinnonendemicnasopharyngealcarcinoma
AT leivoilmo expressionoftolllikereceptorsinnonendemicnasopharyngealcarcinoma
AT minnheikki expressionoftolllikereceptorsinnonendemicnasopharyngealcarcinoma
AT vahlbergtero expressionoftolllikereceptorsinnonendemicnasopharyngealcarcinoma
AT haglundcaj expressionoftolllikereceptorsinnonendemicnasopharyngealcarcinoma
AT hagstromjaana expressionoftolllikereceptorsinnonendemicnasopharyngealcarcinoma
AT irjalaheikki expressionoftolllikereceptorsinnonendemicnasopharyngealcarcinoma